Clinical Trial Update: Study of GA-GCB Enzyme Replacement Therapy in Type 1 Gaucher Disease Patients Previously Treated With Imiglucerase [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial evaluating GA-GCB enzyme replacement therapy in Gaucher disease patients previously treated with imiglucerase has been completed with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gaucher Disease

Drugs mentioned

• GA-GCB (GA-GCB enzyme replacement therapy)
• Imiglucerase (imiglucerase)

Snippet

Sponsor: Shire | Conditions: Gaucher Disease | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2010-09-02